0001209191-22-025160.txt : 20220421
0001209191-22-025160.hdr.sgml : 20220421
20220421160509
ACCESSION NUMBER: 0001209191-22-025160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220419
FILED AS OF DATE: 20220421
DATE AS OF CHANGE: 20220421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desai Veeral
CENTRAL INDEX KEY: 0001855973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40332
FILM NUMBER: 22841432
MAIL ADDRESS:
STREET 1: C/O AGILON HEALTH, INC.
STREET 2: 6210 E HWY 290, SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: agilon health, inc.
CENTRAL INDEX KEY: 0001831097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 371915147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
BUSINESS PHONE: 562-256-3800
MAIL ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
FORMER COMPANY:
FORMER CONFORMED NAME: Agilon Health Topco, Inc.
DATE OF NAME CHANGE: 20201103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-19
0
0001831097
agilon health, inc.
AGL
0001855973
Desai Veeral
C/O AGILON HEALTH, INC.
6210 E HWY 290, SUITE 450
AUSTIN
TX
78723
0
1
0
0
Chief Strategy & Dev. Officer
Common Stock
2022-04-19
4
M
0
106357
1.00
A
384568
D
Common Stock
2022-04-19
4
S
0
106357
22.74
D
278211
D
Common Stock
2022-04-20
4
M
0
106357
1.00
A
384568
D
Common Stock
2022-04-20
4
S
0
106357
22.34
D
278211
D
Options (Rights to Buy)
1.00
2022-04-19
4
M
0
106357
0.00
D
2027-04-27
Common Stock
106357
775351
D
Options (Rights to Buy)
1.00
2022-04-20
4
M
0
106357
0.00
D
2027-04-27
Common Stock
106357
668994
D
Includes restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.90 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.76 to $22.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
These options were granted on April 27, 2017 and fully vested on April 27, 2021.
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
2022-04-21